Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

被引：0
|
作者：
Ahmed, Sairah [1 ]
Lin, Heather [1 ]
Baladandayuthapani, Veera [1 ]
Khan, Mubeen A. [1 ]
Lu, Gary
Rondon, Gabriela [1 ]
Qureshi, Sofia [1 ]
Dinh, Yvonne T. [1 ]
Bashir, Qaiser [1 ]
Shah, Nina [1 ]
Parmar, Simrit [2 ]
Hosing, Chitra M. [1 ]
Popat, Uday [1 ]
Giralt, Sergio A.
Orlowski, Robert Z. [3 ]
Shah, Jatin J.
Champlin, Richard [1 ]
Qazilbash, Muzaffar H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therap, Houston, TX 77030 USA
[2] Mem Sloan Kettering Canc Ctr, Allogene Bone Marrow Transplant Serv Med, New York, NY 10021 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [31] Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation
    Afrough, Aimaz
    Pasvolsky, Oren
    Ma, Junsheng
    Srour, Samer
    Bashir, Qaiser
    Saini, Neeraj
    Hosing, Chitra
    Popat, Uday R.
    Kebriaei, Partow
    Delgado, Ruby
    Ullah, Muhammad R.
    Murphy, Regan
    Manasanch, Elisabet E.
    Lee, Hans C.
    Kaufman, Gregory P.
    Patel, Krina K.
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (06): : 307.e1 - 307.e8
  • [32] Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
    Bergantim, Rui
    Trigo, Fernanda
    Guimaraes, Jose E.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2012, 1
  • [33] Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
    Rui Bergantim
    Fernanda Trigo
    José E Guimarães
    Experimental Hematology & Oncology, 1 (1)
  • [34] Nursing Progress of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
    Chen, Yilu
    Huang, Shuai
    Miao, Linhui
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 : 24 - 24
  • [35] Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation
    Al-Anazi, Khalid Ahmed
    BONE MARROW RESEARCH, 2012,
  • [36] Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Tosi, P.
    Imola, M.
    Mianulli, A. M.
    Tomassetti, S.
    Merli, A.
    Molinari, A.
    Mangianti, S.
    Ratta, M.
    Isidori, A.
    Visani, G.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2012, 4 (01)
  • [37] Autologous hematopoietic cell transplantation for high-risk ALL
    Linker, C.
    Damon, L.
    Martin, T.
    Blume, K.
    Forman, S.
    Snyder, D.
    Wolf, J.
    Negrin, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 460 - 461
  • [38] Autologous hematopoietic cell transplantation for high-risk ALL
    C Linker
    L Damon
    T Martin
    K Blume
    S Forman
    D Snyder
    J Wolf
    R Negrin
    Bone Marrow Transplantation, 2011, 46 : 460 - 461
  • [39] Allogeneic Stem Cell Transplantation for High/Ultra High-Risk Multiple Myeloma
    Weeks, Charles
    Vuppala, Rohan
    Gold, Matthew
    Simon, Abigayle
    Jillella, Anand
    Cortes, Jorge
    Kota, Vamsi
    JOURNAL OF HEMATOLOGY, 2025, 14 (01) : 38 - 42
  • [40] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    G Schilling
    T Hansen
    A Shimoni
    T Zabelina
    J-A Simon-Perez
    N C Gutierrez
    W Bethge
    P Liebisch
    R Schwerdtfeger
    M Bornhäuser
    S Otterstetter
    E M M Penas
    J Dierlamm
    F Ayuk
    D Atanackovic
    U Bacher
    C Bokemeyer
    A Zander
    J S Miguel
    A Nagler
    N Kröger
    Leukemia, 2008, 22 : 1250 - 1255
12345